A simple pressure pump, made from balloons and nylon stockings, means more people in more places will be able to test water contaminants and blood samples.
The ingenious device unveiled in the prestigious Lab on a Chip journal cost just $2 to make, yet works almost as well as its expensive and cumbersome lab counterparts.
Pumps are used to make biological samples flow through microfluidic devices while their contents are identified beneath a microscope.
This DIY pump came from a collaboration between researchers at RMIT University and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, who demonstrated its viability in tests to detect aquatic parasites and cancer cells and to study vascular diseases.
Inspired by football
Study lead author and RMIT engineer, Dr Peter Thurgood,said the team took inspiration for the simple invention from footballs, which hold large pressures when reinforced.
“We started with basic latex balloons, then realised that regular stockings made from nylon and elastane could be a perfect match to reinforce them, allowing them to hold significantly higher pressure and function as pumps,” Thurgood said.
“By simply wrapping three layers of stockings around the latex balloon we were able to increase its internal pressure by a factor of 10 – enough to run many water or blood analyses that would usually require large, expensive pumps.”
Experiments showed the reinforced balloon pump could be used to operate microfluidic devices for several hours without a significant pressure loss.
The pump also fits easily within an incubator and can be left overnight.
A low-cost field tool where it’s needed most
Study co-author and parasitologist at the Walter and Eliza Hall Institute,Associate Professor Aaron Jex, is a leading researcher in global water quality and public health interventions.
He said this simple innovation opened exciting opportunities in field water testing and the ability to test and diagnose patients for infectious pathogens and aquatic micro-organisms at the point-of-care.
“Parasitic micro-organisms have a major impact in impoverished communities in tropical and subtropical regions globally, but also in developed countries including Australia,” Jex said.
“In order to address this there is an urgent need for field-based, low-cost diagnostic tools that work in challenging, sometimes remote and often complex environments very different from a pristine laboratory.”
“As simple as it may look, this device suits those needs really well and could have a big impact.”
Co-author and RMIT biologist, Dr Sara Baratchi, said it also had promising applications for early diagnosis of diseases at home or in the doctor’s surgery.
The balloon pump was tested as a point-of-care diagnostic device for detection of very low concentrations of target cancer cells in liquid samples, and found to work.
“The hydrodynamic force of liquid produced by the reinforced balloon was enough to isolate cells for study, which was really amazing for a $2 pump!”
Baratchi is now working on applying the simplified pump technology to develop organ-on-chip systems that mimic the flow conditions in dysfunctional vessels, to better understand diseases like atherosclerosis that lead to heart attack and stroke.
An opportunity for outreach
RMIT engineer and project leader, Dr Khashayar Khoshmanesh,is a leading researcher in the field of microfluidic based lab-on-a-chip technologies.
He said while microfluidics had made significant progress over the past decade, their widespread application had been limited by the cost and bulk of pumps required to operate them.
“Simplicity is at the heart of our entire research program. By redesigning sophisticated microfluidic devices into simplified ones, we can maximise their outreach and applications for use in teaching or research in the field, not just in sophisticated labs,” he said.
“We envisage these types of pumps also being suitable for student classwork experiments to support capability development in this important area of research from an earlier stage.”
The Latest on: Point-of-care diagnostic device
via Google News
The Latest on: Point-of-care diagnostic device
- Assure Antibody Test for COVID-19 Distributed by MEDformance is First in the U.S. to Receive Point-of-Care Authorizationon October 7, 2020 at 3:56 pm
On September 23rd, the U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for the first serology (antibody) Point-Of-Care (POC) test for COVID-19.
- Point of Care (PoC) Diagnostics Market Size, Share Set to Register 34.6 billion USD by 2025 - Industry Newson October 6, 2020 at 3:33 pm
Diagnostics Market Size and Analysis maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides Point of Care (PoC) Diagnostics Market Growth and ...
- BD Gets CE Mark for Point-of-Care Coronavirus Antigen Teston October 5, 2020 at 8:37 am
Becton, Dickinson and Company BDX — also popularly known as BD — recently received CE mark for its rapid, point-of-care, SARS-CoV-2 antigen test for utilization on the BD Veritor Plus System. The new ...
- Israeli PixCell Medical scores Australia Gov. approval for blood diagnostic device at point-of-careon October 5, 2020 at 4:03 am
The Israeli MedTech company receives approval from the Australian government, which deploys PixCell's diagnostics device as a COVID-19 remote care ...
- Rapid detection of SARS-CoV-2 with portable CRISPR-based mobile phone diagnostic teston October 4, 2020 at 6:11 pm
A large group of researchers from the United States reported developing an amplification-free CRISPR-based mobile phone assay for direct detection of the severe acute respiratory syndrome coronavirus ...
- 7 Diagnostic and Genomic Stocks Storming Into Octoberon October 1, 2020 at 12:22 pm
I gave an update to my Healthcare Innovators members about our Top Ten stocks to buy now, or on pullbacks into October. And what I didn't anticipate was that immediately after in the week of Sep 21, ...
- Adial Pharmaceuticals Announces Sale of 10,000 COVID-19 Antibody Rapid Test Deviceson September 30, 2020 at 6:25 am
We are pleased to report that that among other orders that we have received for the FaStep COVID-19 IgG/IgM Rapid Test Device, yesterday we received an initial purchase order for 10,000 FaStep ...
- Point-of-Care Diagnostics Devices And Equipment Global Market Report 2020-30: Covid 19 Implications and Growthon September 24, 2020 at 10:11 pm
Reportlinker.com announces the release of the report "Point-of-Care Diagnostics Devices And Equipment Global Market Report 2020-30: Covid 19 Implications and Growth" - 7 billion in 2019 to $21.5 ...
- Point-of-Care Diagnostics Devices And Equipment Global Market Report 2020-30: Covid 19 Implications and Growthon September 24, 2020 at 9:48 pm
New York, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Point-of-Care Diagnostics Devices And Equipment Global Market Report 2020-30: Covid 19 ...
- Babson Diagnostics nets new CEO, plus $13.7M for its blood test deviceson September 24, 2020 at 1:00 pm
Babson Diagnostics, a startup looking to make widespread blood sample collection a simpler process, has closed its initial funding round of $13.7 million and gained a new CEO.
via Bing News